SDGR — Schrodinger, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1490978 ·
Last close
$25.66
Market Cap
$1.68B
52W High
$34.00
52W Low
$10.94
ADV30
1,846,638
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 64,491,000 38,253,000 -26,129,000 -37,711,000 611,940,000 246,983,000 310,110,000
Jun 2026 58,889,000 32,432,000 -41,547,000 5,975,000 640,394,000 287,853,000 311,438,000
Mar 2026 58,587,000 29,547,000 -48,794,000 -60,026,000 634,187,000 260,255,000 320,639,000
Dec 2025 87,235,000 57,293,000 -17,157,000 32,511,000 726,160,000 230,517,000 362,107,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-112,575,000
Investing CF
$180,567,000
Financing CF
$4,138,000
CapEx
$-4,199,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.68
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-720,568,000
Inventory
—
Receivables
$70,835,000
ST Investments
$119,375,000
EBIT TTM
$-133,627,000
Pretax Income TTM
$-56,853,000
Interest Exp TTM
—
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$269,201,984
EBITDA
$-127,765,000
Free Cash Flow
$-32,955,876
Enterprise Value
$1,977,088,768
Total Cash
$366,358,016
Total Debt
$104,627,000
Shares Out
65,641,435
Trailing EPS
$-0.79
Book Value
$4.02
ROE
-19.0%
ROA
-13.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 255,869,000 -166,896,000 -103,265,000 726,160,000 362,107,000 364,053,000 13,899,000
Dec 2024 207,539,000 -209,296,000 -187,123,000 823,226,000 401,781,000 421,445,000 -157,368,000
Dec 2023 216,666,000 -177,448,000 40,720,000 802,955,000 254,397,000 548,558,000 -136,733,000
Dec 2022 180,955,000 -146,817,000 -149,186,000 688,587,000 240,682,000 447,894,000 -119,683,000

TTM Snapshot

Revenues TTM
$259,035,000
NetIncome TTM
$-54,335,000
OpCashFlow TTM
—
Assets (Latest)
$640,394,000
Forward EPS
$-1.35

Max Pain — expiry 2026-12-18

max pain strike: $30.00 · spot: $27.20 · call oi: 7,822 · put oi: 6,804
Expected Move to 2026-12-18: ±$5.67 (20.86%) — implied range $21.52 – $32.88 · ATM straddle on $27.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BRVE Braveheart Bio, Inc. $1.69B $18.78 —
SUPN Supernus, Inc. $1.69B $29.04 —
RARE Ultragenyx Pharmaceutical Inc. $1.70B $16.70 —
STOK Stoke Therapeutics, Inc. $1.73B $26.41 —
ZYME Zymeworks Inc. $1.78B $25.84 —

News headlines (Yahoo Finance, 1h cache)

Schrodinger Eyes Growth From AI Assistant Bunsen and Hosted Software Shift
2026-11-13 22:14 · Yahoo
Schrödinger, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
What Schrodinger (SDGR) Said on Its Q3 Earnings Call
2026-11-05 04:14 · Yahoo
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 23:45 · Yahoo
Schrödinger Reports Third Quarter 2026 Financial Results
2026-11-04 21:05 · Yahoo
Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline
2026-10-28 13:00 · Yahoo
Schrödinger to Present at UBS Global Healthcare Conference
2026-10-28 12:30 · Yahoo
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-26 12:30 · Yahoo
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4
2026-10-21 12:30 · Yahoo
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
2026-10-14 15:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.